학술논문

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 4 May 2024, 403(10438):1753-1765)
Subject
Language
English
ISSN
1474547X
01406736